Need the TZIELD COMPASS Support Program START Form?

IT’S FINALLY TIME TO
GET A STEP AHEAD

It's possible for you to take control and delay the onset of insulin-dependent type 1 diabetes

TZIELD is indicated to delay onset of Stage 3 type 1 diabetes (T1D) for people 8 years and older with Stage 2 T1D.

LEARN HOW TZIELD CAN HELPActor Portrayal
A mother wrapping her arms around her son and kissing his cheek while he's wrapped in a beach towel outdoors

It’s Time to Get Proactive

For the first time ever in the treatment of type 1 diabetes, people can act
before visible symptoms, the risk of serious complications, and the need for insulin.
TZIELD could mean more time to prepare for diabetes management.

Not sure where to go first?
Which describes you or your loved one?

A droplet with a no symbol over it

I have not been screened for
type 1 diabetes

Early screening, follow-up testing and staging can tell you whether you are in the window of opportunity for TZIELD treatment.

A droplet

I have been screened for autoimmune type 1 diabetes but have not been prescribed TZIELD

Discover how TZIELD could help if you are an appropriate person for treatment.

A RX prescription

I have been
prescribed TZIELD

Explore your personalized TZIELD COMPASS Support Program.

A group of young girls smiling for a photoActor Portrayal

Stay connected and get
more information about TZIELD.

SIGN UP TODAY
John's TZIELD® (teplizumab-mzwv) type 1 diabetes patient story video

John’s Journey

A fitness enthusiast without any immediate family history of the disease, John did not have diabetes on his radar. Watch his journey from being misdiagnosed to learning he had type 1 diabetes, and you’ll see why he’s passionate about getting the word out about early screening and TZIELD.

Video transcript

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Officiis illo ex praesentium amet tenetur? Doloremque asperiores, quo repudiandae fugit alias reiciendis libero maxime quis, unde dolorem voluptate error vel explicabo?

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Officiis illo ex praesentium amet tenetur? Doloremque asperiores, quo repudiandae fugit alias reiciendis libero maxime quis, unde dolorem voluptate error vel explicabo?

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Officiis illo ex praesentium amet tenetur? Doloremque asperiores, quo repudiandae fugit alias reiciendis libero maxime quis, unde dolorem voluptate error vel explicabo?

SCREENING FOR TYPE 1 IS PRIORITY 1

Type 1 diabetes can affect anyone and has no obvious early warning signs. Early screening could lower the risk of life-threatening complications at diagnosis and is the first step in getting ahead of T1D and knowing whether TZIELD is right for you.

But, the window of opportunity for TZIELD treatment can be short. If you or a loved one hasn’t been screened for type 1 diabetes, find out more and talk to a doctor today.

START TODAY
A mother and her daughter looking at a phone while lounging on a couchActor Portrayal

Want the full or short read?

Understanding how to spot type 1 diabetes early, and if the potential benefits of treatment with TZIELD is right for you, adds up to an important story for your or your loved one's health, and key for a conversation with your doctor. Explore this website in full, or, if you want the highlights, check out our TZIELD Essentials page.

IMPORTANT SAFETY INFORMATION What is the most important information I should know about TZIELD? TZIELD may cause serious side effects. These include:
  • Cytokine release syndrome (CRS). Signs and symptoms may start during the first 5 days of TZIELD treatment and could include fever, nausea, feeling tired (fatigue), headache, muscle and joint pain, or increased liver enzymes in your blood. Tell your healthcare provider right away if you develop any signs and symptoms of CRS during treatment with TZIELD
  • Decrease in white blood cells. TZIELD may cause a decrease in a type of white blood cell called lymphocytes. A decrease in white blood cells is a serious, but common side effect that can affect your body’s ability to fight infections. A decrease in white blood cell counts can happen after your first dose. Your white blood cell counts will start to go back to normal after your fifth dose of TZIELD. Some people may develop longer and more severe decreases in lymphocytes

Your healthcare provider will do blood tests to check your liver and your complete blood counts before you start treatment and during treatment with TZIELD. During and after your treatment with TZIELD, your healthcare provider will check for serious side effects, as well as other side effects, and treat you as needed. Your healthcare provider may temporarily or completely stop your treatment with TZIELD, if you develop liver problems, have a serious infection, or if your blood counts stay too low.

What should I tell my healthcare provider before receiving TZIELD? Before or after receiving TZIELD, tell your healthcare provider about all your medical conditions, including if you:
  • have a serious infection or an infection that does not go away or keeps coming back
  • have recently received or are scheduled to receive an immunization (vaccine). TZIELD may affect how well a vaccine works. Tell your doctor that you are receiving TZIELD before receiving a vaccine
  • are pregnant or plan to become pregnant. TZIELD may harm your unborn baby. Do not receive TZIELD during pregnancy and at least 30 days before a planned pregnancy
  • are breastfeeding or plan to breastfeed. It is not known if TZIELD passes into your breast milk and if it can harm your baby. Talk to your healthcare provider about the best way to feed your baby if you receive TZIELD

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of TZIELD? The most common side effects of TZIELD include:
  • rash
  • leukopenia (decrease in white blood cell counts)
  • headache

These are not all of the possible side effects of TZIELD. Talk to your healthcare provider for more information, and tell them about any side effects you notice. You may report side effects to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.

Please see Medication Guide and Prescribing Information.

What is TZIELD?

TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require insulin injections. TZIELD is for adults and children 8 years of age and older who have Stage 2 type 1 diabetes. This means that they have tested positive for 2 or more type 1 diabetes-related autoantibodies, have abnormal blood sugar levels, and do not have type 2 diabetes.

It is not known if TZIELD is safe and effective in children under 8 years of age.

IMPORTANT SAFETY INFORMATION AND APPROVED USE

What is the most important information I should know about TZIELD? TZIELD may cause serious side effects. These include:
  • Cytokine release syndrome (CRS). Signs and symptoms may start during the first 5 days of TZIELD treatment and could include fever, nausea, feeling tired (fatigue), headache, muscle and joint pain, or increased liver enzymes in your blood. Tell your healthcare provider right away if you develop any signs and symptoms of CRS during treatment with TZIELD
  • Decrease in white blood cells. TZIELD may cause a decrease in a type of white blood cell called lymphocytes. A decrease in white blood cells is a serious, but common side effect that can affect your body’s ability to fight infections. A decrease in white blood cell counts can happen after your first dose. Your white blood cell counts will start to go back to normal after your fifth dose of TZIELD. Some people may develop longer and more severe decreases in lymphocytes

Your healthcare provider will do blood tests to check your liver and your complete blood counts before you start treatment and during treatment with TZIELD. During and after your treatment with TZIELD, your healthcare provider will check for serious side effects, as well as other side effects, and treat you as needed. Your healthcare provider may temporarily or completely stop your treatment with TZIELD, if you develop liver problems, have a serious infection, or if your blood counts stay too low.

What should I tell my healthcare provider before receiving TZIELD? Before or after receiving TZIELD, tell your healthcare provider about all your medical conditions, including if you:
  • have a serious infection or an infection that does not go away or keeps coming back
  • have recently received or are scheduled to receive an immunization (vaccine). TZIELD may affect how well a vaccine works. Tell your doctor that you are receiving TZIELD before receiving a vaccine
  • are pregnant or plan to become pregnant. TZIELD may harm your unborn baby. Do not receive TZIELD during pregnancy and at least 30 days before a planned pregnancy
  • are breastfeeding or plan to breastfeed. It is not known if TZIELD passes into your breast milk and if it can harm your baby. Talk to your healthcare provider about the best way to feed your baby if you receive TZIELD

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of TZIELD? The most common side effects of TZIELD include:
  • rash
  • leukopenia (decrease in white blood cell counts)
  • headache

These are not all of the possible side effects of TZIELD. Talk to your healthcare provider for more information, and tell them about any side effects you notice. You may report side effects to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.

Please see Medication Guide and Prescribing Information.

What is TZIELD?

TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require insulin injections. TZIELD is for adults and children 8 years of age and older who have Stage 2 type 1 diabetes. This means that they have tested positive for 2 or more type 1 diabetes-related autoantibodies, have abnormal blood sugar levels, and do not have type 2 diabetes.

It is not known if TZIELD is safe and effective in children under 8 years of age.